source
- NIH senior adviser promotes MAHA strategy at ADA conference amid skeptical audienceAt the American Diabetes Association meeting in New Orleans, Richard Woychik, a senior adviser to NIH Director Jay Bhattacharya, opened his remarks by endorsing the Make America Healthy Again (MAHA…
- RevMed’s experimental pancreatic cancer drug available via expanded access as FDA voucher program faces potential changesRevMed's experimental pancreatic cancer therapy daraxonrasib has not received FDA approval yet, but the company is offering it through an expanded access (compassionate use) program. Access to the…